## Abstract A total of 111 fresh brain biopsies from patients with primary brain tumors were examined for JC polyomavirus sequences from the Large T antigen encoding region (LT) and the viral non‐coding control region (NCCR). SYBR Green and TaqMan real‐time polymerase chain reaction assays were use
Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle-and large-T antigens
✍ Scribed by Git Reinholdsson-Ljunggren; Torbjörn Ramqvist; Lars Ährlund-Richter; Tina Dalianis
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- French
- Weight
- 576 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
We have used 9 synthetic peptides corresponding to sequences of polyoma virus small-T, middle-T and large-T antigens as immunogens in order to map antigenic epitopes that can induce polyoma-tumor-specific immunity in different mouse strains. We found that immunization of mice with synthetic peptides derived from amino acid (aa) sequences common to all 3 T-antigens (aa I -I 9). or sequences common to only middle-T and small-T (aa 162-176). as well as synthetic peptides unique for middle-T (aa 269-282 and 37 1-38 I). or unique for large-T (aa 108-124, 316-333 and 436449) can induce immunity against polyoma tumors. The synthetic peptides can be divided into 3 types with regard to immunogenicity; (i) peptides that immunize in more than one mouse strain and may represent immunodominant sites, (ii) peptides that may be immunogenic in only one strain, and thus strain-specific, and finally (iii) peptides that do not immunize in the strains tested so far.
📜 SIMILAR VOLUMES